ESCUELA GNOSTICA UNIVERSAL (E.G.U.)
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ESCUELA GNOSTICA UNIVERSAL (E.G.U.) Trademark

Serial Number: 77709614

ESCUELA GNOSTICA UNIVERSAL (E.G.U.) is a trademark filed by Urruticoechea Velasco, Jose Ignacio on April 8, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Urruticoechea Velasco, Jose Ignacio

Urb. Lomas de Gragea Luminosa Villa
Alhaurin de la Torre 29130 , ES

Entity Type: 01

Trademark Details

Filing Date

April 8, 2009

Registration Date

Not Registered

Published for Opposition

July 19, 2011

Goods & Services

Educational services, namely, classes, seminars, workshops and lectures in the fields of medical, homeopathic and pharmaceutical procedures and medical, homeopathic and pharmaceutical treatments; teaching, training, tutoring and courses of instruction at the undergraduate, graduate, and post-graduate level

Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Bandages impregnated with a pharmaceutical or therapeutic substance, namely, natural plants, minerals and vitamins; Biometallic compounds used as component in pharmaceutical preparations for the treatment of respiratory diseases and disorders, infectious diseases, hormonal disorders and for the prevention of osteoporosis, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, ocular disorders or diseases, bacteria-based diseases, diabetes, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for tablets and capsules that facilitates the delivery of pharmaceuticals; Homeopathic pharmaceuticals for use in treatment of respiratory diseases and disorders, infectious diseases, hormonal disorders and for the prevention of osteoporosis, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, ocular disorders or diseases, bacteria-based diseases, diabetes, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of hormonal disorders and for the prevention of osteoporosis; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, Pharmaceutical preparations for skin care; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical skin lotions; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes

Medical and pharmaceutical consultation; health care services, namely, hospitals, long term care facilities, medical clinics, wellness centers, namely, medical clinics, wellness programs; health maintenance organizations and managed health care services organizations; Chiropractic services; and psychological consultation

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Apr 16, 2012 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 16, 2012 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 13, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2011 NPUB
PUBLISHED FOR OPPOSITION
Jul 19, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 13, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2011 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 10, 2011 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
May 24, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 20, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
May 20, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 20, 2011 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 29, 2011 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2011 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2011 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 29, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 29, 2011 REAP
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 30, 2010 GPRN
PRIORITY ACTION E-MAILED
Oct 30, 2010 GPRA
PRIORITY ACTION WRITTEN
Oct 30, 2010 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2010 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2010 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2010 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2010 CRFA
ASSIGNED TO LIE
Feb 11, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 21, 2010 TROA
PETITION TO REVIVE-GRANTED
Jan 21, 2010 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 21, 2010 PROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 4, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jul 4, 2009 GNRT
NON-FINAL ACTION WRITTEN
Jul 4, 2009 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2009 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Apr 14, 2009 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 13, 2009 NWOS
NEW APPLICATION ENTERED
Apr 11, 2009 NWAP